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The phenomenon of local tissue  reactivity was first described by Shwartzman in 
1928 (cited in reference 1)  and now is generally known as the local Shwartzman re- 
action. It is characterized by dermal hemorrhage and necrosis which develop a  few 
hours after the second of two injections of a culture filtrate of Gram-negative microor- 
ganisms, or of a lipopolysaccharide material from such cultures. The first, or prepar- 
atory injection is  made intradermally,  usually in the abdominal skin of the rabbit; 
the  second, or provocative  injection,  is  given  intravenously  about  24  hours  later. 
Within a few hours after the intravenous injection, purple-black areas  of hemorrhage 
and necrosis appear at the site of intradermal injection. 
Until recently, little was known concerning the mechanisms involved in this phe- 
nomenon, and it was considered to be a manifestation of some type of immune tissue 
response. Many of the features of this reaction have now been studied, and the im- 
portance of several non-antigenic factors in the production of this  lesion has been 
established  (2-5). The initial alterations  appear to be confined to the site of intra- 
dermal  injection,  and  resemble  a  mild  inflammatory reaction.  Concomitantly, bio- 
chemical changes occur at the prepared site. These include an increased lactic acid 
content, and an increase in aerobic and anaerobic glycolysis. These changes become 
maximal 24 hours after the preparatory injection, but are generally insufficient,  by 
themselves,  to induce the hemorrhagic lesion.  If, however,  the provocative dose of 
bacterial polysaccharide is given at this time, there can be seen the development of 
progressive damage at the prepared site. Thrombi of platelets and leucocytes appear 
in the blood vessels,  intravascular clotting occurs, and there is hemorrhage into the 
area and, in time, necrosis develops. 
Vasoconstriction,  which  occurs  in  rabbits  following  administration  of  bacterial 
polysaccharides (2, 6), may contribute to the local damage by impairment of the blood 
supply  to the area.  Peripheral  vasoconstriction would predispose  to thrombus for- 
mation, and, in turn, local thrombosis would tend to intensify and prolong circulatory 
deficiencies. Development of hemorrhage and necrosis could result from the cumulative 
effect of altered metabolism of the skin, of less efficient removal of metabolic products, 
and of anoxia. 
These  studies  were  undertaken  to obtain  information  which would help  to 
evaluate the importance of peripheral vasoconstriction during the provocative 
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phase of the  Shwartzman reaction.  This report presents  data  which indicate 
that peripheral  vasoconstriction is involved in the Shwartzman phenomenon, 
and, indeed, may be a major factor in its development. 
Materials and Methods 
Previously untreated,  young albino rabbits of both sexes weighing 1.2 to 2.0 kg. were used 
in these experiments. The hair was removed from the injection sites with electric clippers on 
the day the intradermal  injections were made. A polysaccharide preparation  from Serratia 
marces¢¢ns (Perrault and Shear, Lot No. P-35) was used in all experiments (7). It was admin- 
istered in solution in commercial, sterile, pyrogen-free saline. The preparatory dose was given 
intradermally,  and the provocative dose was given by ear vein 24 hours later. Development 
of an area of purple-black necrosis at the prepared site within 6 hours after provocative in- 
jection,  and persisting  for 24 hours,  was considered a positive  reaction.  No attempt was 
made to grade the intensity of response. Differences between experimental and control groups 
of rabbits were evaluated by the chi square test. 
The following drugs were used:-- 
Dibenamine (Smith, Kline and French Laboratories, Philadelphia) 
SY-28(N-ethyl-N-[2-bromoethyl]-l-naphthalenemethylamine)(Courtesy of  Dr.  A.  C. 
Brat-ton, Parke, Davis and Co., Detroit) 
Dihydroergotamine (Sandoz Pharmaceuticals, New York.) 
Epinephrine, synthetic (Winthrop-Stearns, Inc., New York) 
l-Norepinephrine, synthetic (Winthrop-Stearus, Inc., New York) 
5-Hydroxytryptamine (Courtesy  of Dr.  R.  K.  Richards,  Abbott Laboratories,  North 
Chicago) 
DipI~,nhydramine  (benadryl)  (Parke,  Davis  and Co.,  Detroit) 
Tripd~namine (pyribenzamine)  (Ciba Pharmaceutical  Products,  Inc.,  Summit, New 
Jersey) 
Mechlorethamine (mustargen) (Merck and Co., Inc. Rahway, New Jersey) 
Heparin (Hynson, Westcott and Dunning, Inc., Baltimore) 
EXI~ERIM/ENTAL RESIFLTS 
1. Site of Intradermal Injection: 
In most experiments the local Shwartzman reaction has been elicited in high 
percentage  only in the  abdominal skin  of rabbits  (1,  2).  If this  phenomenon 
occurs preferentially in abdominal skin, it would argue against the importance 
of peripheral  vasoconstriction  in  the  development  of  the  reaction,  because 
polysaccharide-induced  vasoconstriction occurs in all  skin  areas.  In order  to 
obtain definite  information  on this  question,  therefore,  other skin areas  were 
tested. 
Four sites  (right  ear,  left  costovertebral  angle, right  upper quadrant  of abdomen,  and 
fight hind leg) were prepared by intradermal  injection of 0.25 rag. of polysaccharide in 0.125 
mi. saline. Twenty-four hours later,  a provocative dose of 1 rag. polysacchafide was admin- 
istered intravenously. 
The high incidence of positive reactions (Table I) which was obtained in all 
sites  indicates  that  the  ability  of the  skin  to develop the  characteristic  local DAVID  P.  RALL  AND  MARGARET  G.  KELLY  645 
lesion is not restricted to one area. This finding is consistent with the concept 
that generalized peripheral vasoconstriction may play an essential part in the 
development of the local Shwartzman phenomenon. 
2. Action of Autonomic  Blocking Agents: 
Certain adrenolytic drugs have been reported to block, at least in part, the 
vasoconstriction induced by intravenous administration of pyrogenic bacterial 
polysaccharides  (6).  Indication  that  vasoconstriction  is  important  in  the 
Shwartzman reaction was obtained indirectly in the following experiments in 
which the incidence of positive reactions was reduced by administration of 
adrenergic blocking drugs just prior to the provocative injection of polysac- 
charide. The results obtained when SY-28,  dibenamine, or dihydroergotamine 
TABLE  I 
Production  of Local  Shwartzman  Reaction  in  Several  Different  Areas 
Skin area tested 
Abdomen (right upper quadrant) .................... 
Ear (right) ....................................... 
Costovertebral angle (left) .......................... 
Hind leg (right) ................................... 
Positive reactions* 
No.  Per cent 
7  58 
6  50 
8  75 
11  92 
* 12 rabbits given 0.25 mg. polysaccharide intradermaUy in each site, followed in 24 hours 
by 1 mg. intravenously. 
were given are summarized in Table II. The percentage of positive reactions 
was reduced in those groups of rabbits given either 2.5 to 4.0 mg./kg.  SY-28 
intraperitoneally,  or  20  to  30  mg./kg,  dibenamine  intraperitoneally.  The 
reason for the failure of the highest dose levels of SY-28 to reduce the number of 
positive responses is unknown. Dihydroergotamine at the level of 2 mg./kg, has 
no effect on the number of positive reactions, and this drug may have a weaker 
adrenolytic action than the others (8). Although both SY-28 and dibenamine, 
in suitable doses, reduced the number of Shwartzman reactions significantly, 
about 40 per cent of the animals still developed the characteristic lesion. This 
may be  related  to  the  inability of these  drugs  to  block  completely certain 
cardiovascular reflexes which seem to be dependent primarily on nerve impulses 
mediated through the sympathetic nervous system. These agents are highly 
effective against circulating epinephrine or norepinephrine, but are less effective 
against nerve mediated vasoconstriction (8, 9). 
3. Action of Antihistaminic Drugs: 
Since  SY-28  and,  to  a  lesser  extent,  dibenamine  have  an  antihistaminic 
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strong  antihistaminic  activity,  diphenhydramine,  and  tripelennamine,  was 
studied. 
The preparatory and provocative dose schedule  of  polysaccharide  in these experiments 
was the same as that used to test the autonomic blocking agents. The antihistaminic drugs 
were given subcutaneously  5 minutes before, and at 1, 2, and sometimes 3 hours  after the 
provocative dose of polysaccharide.  As indicated in Table III, these two antihistaminic drugs 
had no statistically  significant effect on the number of positive Shwartzman reactions elicited 
by bacterial polysaccharide. 
TABLE II 
Effect of Adrenergic Blocking Drugs on the Shwartzman Reaction 
SY-28 
Dibenamine 
Dihydroergotamine 
Drug  Dose (i.p.)  Significance§ 
Controls 
mg./kg. 
5.4 
5.0 
4.0 
3.2 
2.5 
1.5 
30.0 
20.0 
15.0 
7.5 
2.0 
0.7 
Time* 
1 hr. 
1  tc 
1  " 
1  u 
1  " 
liar. 
1  cc 
1  ~c 
5-10 min. 
5-10  " 
123 
No. of  Positive 
rabbits~  reactions 
per cent 
10  100 
18  78 
16  50 
22  36 
20  6O 
15  87 
10  50 
20  55 
7  57 
13  85 
8  88 
8  75 
88 
* Expressed  as time before intravenous injection  1yen. 
:~ Three abdominal sites were prepared on each rabbit by 
mg., 0.25 mg., and 0.50 rag. polysaccharide respectively. 
None 
4¢ 
P  <  0.01 
P  <  0.01 
P  <  0.01 
None 
P  <  0.01 
P  <  0.01 
None 
st 
None 
gc 
intradermal injection of 0.125 
§ Comparisons  made with control group not given blocking drug. P value by chi square 
test corrected for continuity. 
It  seemed  unlikely,  therefore  that  SY-28  and  dibenamine  inhibited  the 
Shwartzman phenomenon  by acting to block histamine, but rather that they 
produced this resnlt by virtue of their ability to cause adrenergic blockade. 
4. Effect of Vasoconstrictor Drugs: 
The  use  of autonomic  blocking agents furnished  only indirect evidence in 
support of the hypothesis that peripheral vasoconstriction is important in the 
development of the local Shwartzman phenomenon.  More direct information 
was  obtained,  however,  by  substituting  vasoconstrictor  drugs  for  bacterial DAVID P. RALL AND  MARGARET  G. KELLY  647 
polysaccharide as the provocative agent. These drugs were administered either 
intravenously or locally at the prepared skin site. 
(a) Intravenous Administration.-- 
In one group of experiments, either/-epinephrine,/-norepinephrine,  or 5-hydroxytrypta- 
mine was given 24 hours after a preparatory  dose of 1 or 4 nag polysaccharide intradermally. 
They were given by constant venoclysis,  or by repeated intravenous injection every 15 minutes 
over a 2 to 4 hour period. 
TABLE III 
Effect of Antihistaminic Drugs on Local Shwartzman Reaction* 
Drug 
Diphenhydramine 
Tripelenamine 
Controls 
Dose~ 
mg./kg. 
10.0 
5.0 
3.3 
8.0 
No. of rabbits 
8 
7 
15 
123 
Positive reactions 
~eil" C~nt 
62 
71 
73 
100 
88 
Significance§ 
None 
None 
* Three abdominal sites were prepared on each rabbit by intradermal injection of 0.125 
mE., 0.25 rag., and 0.50 mE. polysaccharlde respectively. 24 hours later, 0.8 mE. polysaccharide 
given intravenously. 
:~ Total dose; equally divided fractions were administered subcutaneously 5 minutes before 
the intravenous polysaccharide, and 1, 2, and sometimes 3 hours after the polysaccharide 
injection. 
§ Comparisons made with control group not given blocking drug. P value by chi square 
test corrected for continuity. 
No local Shwartzman reactions were elicited by this procedure, even at toxic 
dose levels (Table IV). 
( b  ) Intradermal Administration.-- 
In order to obtain more ISronounced  vasoconstriction at the prepared skin site, these vaso- 
constrictor drugs were also injected directly into skin areas which had been prepared in the 
usual way by intradermal  injection of varying dose levels of polysaccharide 24 hours pre- 
viously. The present experiments in which varying amounts of epinephrine, norepinephrine, 
or 5-hydroxytryptamine  were injected directly into the prepared  site, confirm and extend 
previous reports that local epinephrine can provoke this reaction  (11-13). The drugs were 
prepared in concentrations so that the desired quantity of drug was contained in 0.25 to 
0.5 ml. of pyrogen-free saline. The control animals were injected intradermally with the py- 
rogen-free saline and showed no positive responses. The results have been summarized in 
Table V. 
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relatively low dose levels of 25 #g. provoked positive Shwartzman reactions. 
Norepinephrine induced a lower incidence of positive reactions; and 5-hydroxy- 
tryptamine was essentially ineffective  in the dosage used. The differences  in 
results obtained with these three drugs may reflect the degree of their effective- 
Effect of Intravenous Administration 
Drug 
Epinephrine ....................... 
Norepinephrine .................... 
Norepinephrine ..................... 
5-hydroxytryptamine ............... 
5-hydroxytryptamine ................ 
TABLE IV 
f Vasoconstrictor  Drugs on Shwartzman Reaction 
To~li.v. do~  No. of rabbits 
mg. 
1.0  6 
0.1  4 
2.0  2 
20.0  4 
50.0  2 
Positive reactions 
0* 
0* 
of 
0* 
0~ 
* Received 1.0 mg. polysaccharide intradermally 24 hours previously. 
5 Received 0.5  rag.  polysaccharide intradermaIly 24 hours previously. 
TABLE V 
Effect of Injection of Prepared Skin Sites with Vasoconstrictor Drugs 
Intrade________~l  vasoconstrictor 
Drug  Dose 
Epinephrine  0 ,Ig00 
0.050  i 
0.025 
Preparatory dose of  polysaccharide,*  mg.$ 
2.0  1.0  0.25  None 
Norepinephrine 
5-hydroxytryptamine 
1.00 
0.25 
0.50 
0.10 
m 
1/9 
1/9 
i 
0.5 
7/95  ~2/~2 
5/8  122/40 
5/11  2/8 
--  1/4 
2/10  3/8 
--  0/6 
--  0/18 
2/7 
1/2 
1/8 
0/4 
0/8 
0/4 
o/3 
* Injected intradermally 24 hours prior to vasoconstrictor. 
$ Numerator refers to number of positive hemorrhagic and necrotic reactions, denomin- 
ator, to number of rabbits tested. 
ness as local vasoconstrictors (14). It is apparent therefore that a typical local 
Shwartzman reaction can be induced by drugs which are potent vasoconstric- 
tors, presumably through the mechanism of intense local vasoconstriction. 
(c)  Effect  of SY-28,  Heparin,  and  Nitrogen  Mustard  on  the  Epinephrine- 
Induced Shwartzmau Reaction.-- 
In  view  of  these  observations,  it  seemed appropriate  to  investigate  the 
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previously have been shown to block the classical Shwartzman reaction, on the 
production of the dermal lesion by the local use of vasoconstrictor drugs. 
The development of intravascular thrombosis is a  prominent feature of the 
classic  Shwartzman  phenomenon.  Impairment  of  local  circulation,  due  to 
severe vasoconstriction, might lead to thrombosis,  particularly in an area of 
inflammation, and the prepared skin site is such an area. In an effort to separate 
primary vasoconstriction from possible secondary thrombosis, the effects of an 
adrenolytic agent and of an anticoagulant were tested for their ability to block 
the epinephrine-induced reaction. 
TABLE VI 
Effect of lteparin and Adrenergic Blocking Drug on Epinephrine Induced Shwartzman Recxtion 
Positive  Significance§  Drugs*  Dose  No. of rabbits~  reactions 
rag./kg,  per cent 
Heparin ........................  25(X 3)  15  [  80  None 
SY-28 ..........................  3.5  ~  I  11  P <  0.05 
Controls ........................  None  55  -- 
* Heparin was given intravenously 5 minutes before, and 2 and 4 hours after the epineph- 
rine; SY-28 was given intraperitoneally I hour before the epinephrine. 
All rabbits given 500/~g. polysaccharide  intradermally; 24 hours later 50/~g. epinephrine. 
§ Comparisons made with control group not given blocking drug. P value by chi square 
test corrected for continuity. 
Epinephrine, 50 #g., was injected intradermally into sites prepared 24 hours previously by 
0.5 rag. of bacterial polysaccharide intradermally in 0.25 ml. saline. Heparin was given at a 
dose level of 25 mg./kg. 5 minutes before, and 2 and 4 hours after the epinephrine; SY-28 
was given at a dose of 3.5 mg./kg., intradermaUy 1 hour prior to the epinephrine. These 
dosage schedules will cause a significant decrease in the incidence of positive reactions in 
response to bacterial polysaccharide. 
In the heparinized animals the reactions provoked by epinephrine appeared 
more intense and were uniformly larger than those in the control animals, and 
the incidence of positive reactions was not decreased (Table VI). In the animals 
pretreated with SY-28, almost complete inhibition of the reaction was noted. 
The effectiveness of the adrenergic blocking drug was not unexpected since it is 
known  to  be more active as  an inhibitor  of circulating  epinephrine  than  of 
sympathetic  nerve  mediated  impulses  (8).  These  observations  support  the 
thesis that vasoconstriction is the primary factor in the epinephrine-induced 
reaction, at least, and that thrombus formation, as seen in the classic Shwartz- 
man reaction is less important and may indeed be secondary to vasoconstric- 
tion. 
It has been reported that alterations in the white blood cells, particularly in 
the polymorphonuclear leucocytes may be of importance in  the  classic local 650  VASOCONSTRICTION  IN  SHWARTZMAN  REACTION 
Shwartzman reaction since pretreatment of rabbits with granulopenic doses of 
nitrogen mustard renders such animals incapable of developing the reaction (4). 
To investigate the role of leucocytes in the epinephrine-induced reaction, a 
series of animals was rendered leucopenic with nitrogen mustard. 
Mustargen was given intravenously, 2.0 mg./kg., to part of a group of rabbits 3 days prior 
to the intradermal dose of 0.25 mg. polysaccharide and 24 hours later 0.1 mg. of epinephrine 
was given into the prepared site of each animal. At this time the mean white blood ceU count 
for the rabbits treated  with the mustard  was 460 WBC/mm.  3 with a  s.E.  of 4-120. 
TABLE  VII 
Effect  of Nitrogen  Mustard  on  Epinephrine-Induced  Shwartzman  Reaction 
Drugs* 
Nitrogen mustard .............. 
Controls ....................... 
Dose 
mg./kg. 
2.0 
No. of rabbits~;  Positive re-  Significanc~ 
actions 
per cent 
67  None 
55 
* The nitrogen mustard was given intravenously 3  days before the preparatory dose of 
polysaccharide. 
~; All rabbits given 500 #g. polysaccharide intradermally; 24 hours later 100 gg. epineph- 
rine. 
§ Comparisons made with control group not given blocking drug. P value by chi square 
test corrected  for continuity. 
Not only was there a  high incidence of positive reactions in the nitrogen 
mustard group (Table VII) but furthermore it was noted that the reaction in 
the treated group were more severe than in the controls. These findings suggest 
that the leucocytes play a less significant role in the epinephrine-induced, than 
in the classic, Shwartzman reaction. 
DISCUSSION 
Information concerning the factors involved in the Shwartzman reaction has 
been derived largely from experiments designed to inhibit this reaction by the 
use of various drugs. It is convenient to consider some of the factors important 
in this reaction in terms of their pharmacologic antagonists. 
Heparin,  as well as certain coumarin derivatives, inhibits the Shwartzman 
reaction when administered at levels which practically prevent coagulation of 
blood and  thus minimize or abolish the formation of intravascular thrombi 
(2, 15, 16). The effect of these diverse anticoagulants furnishes strong evidence 
that thrombus formation is an important factor in the development of the 
Shwartzman reaction. The thrombosis apparently begins around the leucocyte 
platelet clumps which occur after the provocative dose. Since nitrogen mustard, 
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as well as leucopenia (17), it is possible that this compound acts to minimize  or 
prevent the formation of the leucocyte platelet clumps which normally develop 
after the provocative dose. This would indicate a basic similarity in the mech- 
anism of action of both nitrogen mustard and heparin and might help explain 
at least, in part, why neither drug inhibits the epinephrine-induced reaction. 
The inhibition of the Shwartzman reaction by adrenolytic drugs (Table II) 
and provocation of a  typical lesion  by epinephrine  (Table V) suggest that  a 
major factor in precipitating the local lesion may be vasoconstriction. Recently 
bacterial polysaccharide endotoxins were reported to potentiate the action of 
epinephrine  and it was noted that  a  characteristic  lesion  of hemorrhage and 
necrosis  could be produced by a  single intradermal  injection of a  mixture of 
polysaccharide  and  epinephrine  (13,  18).  This  reaction,  also,  is  intensified 
rather  than  inhibited  by nitrogen  mustard  and  heparin.  These observations 
suggest  the  possibility  that  if  small  but  still  significant  amounts  of  poly- 
saccharide remain in the prepared site for some period of time,  this residual 
polysaccharide may act in conjunction with the epinephrine  liberated in re- 
sponse to  the  intravenous  injection  of polysaccharide  and  thereby intensify 
the  vasoconstriction  produced  in  the  prepared  site  from  the  intravenous 
polysaccharide. This may well be a key factor in the genesis of the local anoxia. 
S~MARY 
The local Shwartzman reaction was provoked in the skin of the ear, hind leg, 
and costovertebral angle of the rabbit, as well as in the ventral abdominal skin. 
Certain adrenergic blocking drugs reduced the incidence of positive reactions 
when given prior to the provocative dose of bacterial polysaccharide. 
Epinephrine and other vasoconstrictor drugs administered intradermally into 
the prepared skin site produced typical hemorrhagic-necrotic lesions when the 
usual intravenous injection of polysaccharide was omitted. This reaction could 
be blocked by adrenergic blocking drugs,  but appeared to be augmented  by 
heparin or nitrogen mustard. 
A hypothesis has been developed to help explain the mechanism of the local 
Shwartzman reaction. Following the preparatory dose, tissue metabolic changes 
occur which lead to increased lactic acid production and render the area partic- 
ularly  susceptible  to  anoxia.  Following  the  provocative  dose,  adrenergic 
vasoconstriction  occurs.  It  is  suggested  that  this  vasoconstriction  may  be 
intensified  at the prepared site by small  residual amounts of the preparatory 
dose of polysaccharide which might potentiate the action of the epinephrine. 
The anoxia initiated by the vasoconstriction is prolonged and intensified  by 
the  formation  of  intravascular  thrombi  around  clumps  of  leucocytes and 
platelets. This anoxia, superimposed on the local metabolic changes, leads to the 
characteristic lesion of hemorrhage and necrosis. Thus a combination of factors, 652  VASOCONSTRICTION  IN  SHWARTZM.AN  REACTION 
all of causal importance and largely due to known pharmacologic properties of 
bacterial lipopolysaccharide, occur in specific  sequence to lead to the classic 
local Shwartzman reaction. 
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